CLOV CLOVER HEALTH INV CORP

Clover Health Appoints Seasoned Healthcare Executive as Chief Operating Officer for Medicare Advantage Operations

Clover Health Appoints Seasoned Healthcare Executive as Chief Operating Officer for Medicare Advantage Operations

New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients

FRANKLIN, Tenn., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health” or “Clover”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced the appointment of Joseph Brand as Chief Operating Officer (COO) for its Medicare Advantage (MA) plan. Mr. Brand will oversee core MA operations and drive performance improvements, with a focus on improving healthcare delivery in New Jersey by leveraging operational efficiencies and technological innovation.

Mr. Brand brings nearly 20 years of healthcare leadership experience, having held prominent positions in healthcare operations and technology. Most recently, he served as COO at Jefferson Health Plans, where he spearheaded the creation of a Business Process as a Service (BPaaS) offering, Prior to that, Mr. Brand held senior roles at Horizon Blue Cross Blue Shield of New Jersey, where he played a key role in transforming healthcare delivery and supporting New Jersey physicians. His extensive knowledge of the New Jersey market reinforces Clover Health’s commitment to enhancing the quality of care in the state and investing in local healthcare infrastructure.

“As a proud lifelong New Jerseyan, I’m truly impressed by Clover’s unwavering dedication to our state,” said Brand. “By championing independent physicians, Clover strengthens the core of our local communities, and their affordable plans provide seniors with vital access to high-quality healthcare. After years of insight into the healthcare system, I firmly believe Clover has transformed New Jersey into one of the leading states for Medicare beneficiaries.”

Throughout his career, Mr. Brand has demonstrated a proven track record of success in driving large-scale operational transformations, optimizing costs, and implementing innovative solutions to improve business performance. During his tenure at Jefferson Health Plans, he was instrumental in building scalable processes to support Medicare Advantage and Medicaid programs and integrating advanced technology such as AI and automation into day-to-day operations. At Horizon Blue Cross Blue Shield of NJ, Mr. Brand led enterprise-wide technology initiatives, including the transformation of critical systems, and helped steer the organization toward digital innovation and enhanced customer experiences.

In his new role at Clover Health, Mr. Brand will be responsible for managing Clover’s Medicare Advantage operations with a focus on optimizing operational processes to enhance performance and drive the company’s value-based care initiatives through advanced technology and data-driven solutions.

“Joe’s appointment underscores Clover’s unwavering commitment to operational excellence and supporting local healthcare providers,” said Jamie Reynoso, CEO of Medicare Advantage, Clover Health. “His vast experience in driving efficiency and utilizing cutting-edge solutions will be instrumental in elevating our Medicare Advantage operations and ensuring outstanding service for our members and the physicians we partner with across New Jersey.”

For information on Clover Health’s Medicare Advantage plans, visit. For information on Clover Health Investments, Corp. visit .

About Clover Health:

Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on , as well as the earlier identification and management of and .

Press Contact:

Andrew Still-Baxter

Investor Relations Contact:

Ryan Schmidt



EN
26/09/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CLOVER HEALTH INV CORP

 PRESS RELEASE

Clover Health Reports Second Quarter 2025 Results; Delivering Strong S...

Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-yearSecond quarter 2025 Total revenues of $478 million, up 34% year-over-yearSecond quarter 2025 profitability metrics with GAAP Net loss of $11 million, Adjusted EBITDA of $17 million, and Adjusted Net income of $17 million Updates Full Year 2025 Guidance: Increases Average Medicare Advantage membership to 104,000 - 108,000, representing 32% growth year-over-year at the midpointMaintains Insurance revenue between $1.800...

 PRESS RELEASE

Primary Care Physician Use of Counterpart Assistant Technology Linked ...

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis, increased specialty care, and meaningful reductions in hospitalizations (15% lower) and 30-day readmissions (18% lower). WILMINGTON, Del., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary o...

 PRESS RELEASE

Clover Health Applauds White House and CMS’ Push to “Tear Down Digital...

Clover Health Applauds White House and CMS’ Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians Clover Health’s AI platform, Counterpart Assistant, already connects to a majority of the data networks named in yesterday’s pledge – eliminating the “digital walls,” delivering proven outcomes in chronic disease care, and supporting independent doctors caring for seniors in rural and other underserved areas WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), ...

 PRESS RELEASE

Counterpart Health Appoints Vicky Bruner as Vice President of Operatio...

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today announced the appointment of Vicky Bruner as Vice President of Operations. As Counterpart scales to meet growing demand from payors and providers nationwide, Bruner will lead several critical functio...

 PRESS RELEASE

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual...

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the Canaccord Genuity 45th Annual Growth Conference on Tuesday, August 12, 2025, at 11:00 a.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at . About Clover Health:Clover Health (Nasdaq: CLOV) i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch